European Journal of Pediatrics

, Volume 152, Supplement 1, pp 52–55 | Cite as

The long-term outcome of patients with glycogen storage disease type Ia

  • G. P. A. Smit
Treatment and complications in GSD type Ib


Forty-one patients (16 females and 25 males) over 10 years of age from five different European centres were studied retrospectively. Of those patients 19 were below the 3rd percentile for height. Hypoglycaemia was still reported in 6 patients. Hepatomegaly was present in 39 out of 40, while 11 out of 27 reported patients had marked hepatomegaly (>10 cm below the costal margin in the midclavicular line). Adenomas were detected in 11 out of 39 patients, α-1-fetoprotein was reported to be within normal limits in a total of 22 patients of whom 6 had adenomas. Blood cholesterol concentration was elevated in 31 out of 38 patients, in 7 greater than 10.0 mmol/l. Blood triglycerides were elevated in 29 out of 34 patients, in 8 patients greater than 4.0 mmol/l. Blood uric acid concentration was elevated in 19 out of 35 patients, 12 of them being treated with allopurinol. Mental development was reported to be normal in 32 out of 37 patients. Since limited information on treatment was available no significant differences between treatment groups could be detected. In order to evaluate the effect of treatment, 20 patients (10 females and 10 males) of one centre were studied before and after at least 5 years of treatment. This treatment consisted of frequent feedings during the day together with nocturnal gastric drip feeding. Patients were divided into responders (n=16) and non-responders (n=4) depending on their (change in) SDS (standard deviation score) for height. Liver adenomas were detected in 3 patients, of which one was a non-responder. Alpha-fetoprotein was normal in all patients. With increasing age a gradual increase in blood lipids and some apolipoproteins could be detected, non-responders tending to have higher concentrations of triglycerides, cholesterol, Apo-CIII and Apo-E. Non-responders had significantly higher “fasting” blood lactate and nocturnal urinary lactate concentrations. Virtually all patients had abnormally elevated glomerular filtration rates, but no significant difference was found between responders and non-responders. Older patients may develop normochromic anaemia. Thrombocyte aggregation was abnormal in 4 out of 16 patients, of which one was a non-responder.

Key words

Glycogen storage disease Glucose-6-phosphatase Retrospective study Long-term outcome 



glycogen storage disease


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Alaupovic P, Fernandes J (1985) The serum apolipoprotein profile of patients with glucose-6-phosphatase deficiency. Pediatr Res 19: 380–384PubMedGoogle Scholar
  2. 2.
    Baker L, Dahlem S, Godfarb S, Kern EFO, Stanley CA, Egler J, Heymans S (1989) Hyperfiltration and renal disease in glycogen storage disease, type I. Kidney Int 35: 1345–1350PubMedGoogle Scholar
  3. 3.
    Chen Y-T, Coleman RA, Scheinmann JI, Kolbeck PC, Sidbury JB (1988) Renal disease in type I glycogen storage disease. N Engl J Med 318: 7–11PubMedGoogle Scholar
  4. 4.
    Coire CI, Qizilbash AH, Castelli MF (1987) Hepatic adenomata in type Ia glycogen storage disease. Arch Pathol Lab Med 111: 166–169PubMedGoogle Scholar
  5. 5.
    Fernandes J (1990) The glycogen storage diseases. In: Fernandes J, Saudubray J-M, Tada K (eds) Inborn metabolic diseases. Springer Verlag, Berlin Heidelberg New York, pp 69–88Google Scholar
  6. 6.
    Hers H-G, Van Hoof F, De Barsy T (1989) Glycogen storage diseases. In: Scriver CR, Bedaudet AL, Sly WS, Valle D (eds) The metabolic basis of of inherited disease, 6th ed. McGraw Hill, New York, pp 425–452Google Scholar
  7. 7.
    Reitsman WCC, Troelstra JA, Luijk WHJ van, Smit GPA, Fernandes J (1990) Hyperfiltration in patients with glycogen storage disease type I. Pediatr Nephr. 4: C49Google Scholar
  8. 8.
    Tanner JM, Whitehouse RH, Hughes PCR, Vince FP (1971) Effect of human growth hormone treatment for 1 to 7 years of growth of 100 children, with growth hormone, deficiency, low birth weight, inherited smalness. Turner's syndrome and other complaints. Arch Dis Child 46:745–782PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1993

Authors and Affiliations

  • G. P. A. Smit
    • 1
  1. 1.Department of PaediatricsUniversity Hospital of the University of GroningenGroningenThe Netherlands

Personalised recommendations